Xenon Pharmaceuticals Inc. (XENE) Profit Margins
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
XENEXenon Pharmaceuticals Inc.Follow XENE — free
—
Price chart with a free account
- Market cap
- 3.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 11 Nov, in 18 days
| Line | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | 39.1% | -60.1% | -1376.4% | -10474.3% | -627.0% | -97.3% | -428.4% | -1368.9% | -4974.3% | — | |
| Net margin | 45.9% | -101.1% | -1275.5% | -9872.7% | -609.1% | -89.7% | -427.8% | -1328.9% | -4612.1% | — | |
| FCF margin | -4.5% | -119.8% | -1100.7% | -9337.9% | -87.2% | -157.8% | -388.1% | -1101.6% | -3732.2% | — |
USD billions · SEC XBRL
Every figure on this page comes from Xenon Pharmaceuticals Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.